FANG-JU LINCHI-CHUAN WANGHsu, Chien-NingChien-NingHsuYang, Chen-YiChen-YiYangCHIH-YUAN WANGOu, Huang-TzHuang-TzOu2023-02-142023-02-142021-10-071475-2840https://scholars.lib.ntu.edu.tw/handle/123456789/628057To assess the effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) for type 2 diabetes on kidney outcomes stratified by patient baseline estimated glomerular filtration rate (eGFR) levels (i.e., eGFR ≤ 60, 60 < eGFR ≤ 90, and eGFR > 90 mL/min/1.73 m2).enEstimated glomerular filtration rate; Kidney function; Sodium glucose cotransporter-2 inhibitors; Type 2 diabetes[SDGs]SDG3Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center studyjournal article10.1186/s12933-021-01396-2346201822-s2.0-85116515400WOS:000705851000001https://api.elsevier.com/content/abstract/scopus_id/85116515400